Compounds > nipradilol
Page last updated: 2024-08-25

nipradilol and ng-nitroarginine methyl ester

nipradilol has been researched along with ng-nitroarginine methyl ester in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eto, Y; Honda, K; Natori, K; Nihei, H; Nitta, K; Tsutsui, T; Uchida, K; Yumura, W1
Gaudette, GR; Horimoto, H; Krukenkamp, IB; Saltman, AE1
Isenoumi, K; Kitaoka, Y; Kobayashi, S; Kumai, T; Ueno, S1
Inada, H; Ishimitsu, T; Matsuoka, H; Minami, J; Ono, H1
Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y1

Other Studies

5 other study(ies) available for nipradilol and ng-nitroarginine methyl ester

ArticleYear
Nipradilol inhibits DNA synthesis by regulating nitric oxide synthesis in cultured rat mesangial cells.
    European journal of pharmacology, 1998, Feb-26, Volume: 344, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Cattle; Cells, Cultured; DNA Replication; Enzyme Inhibitors; Glomerular Mesangium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Thymidine

1998
Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
    The Annals of thoracic surgery, 1999, Volume: 68, Issue:3

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rabbits; Ventricular Pressure

1999
Nipradilol induces vasodilation of canine isolated posterior ciliary artery via stimulation of the guanylyl cyclase-cGMP pathway.
    Life sciences, 2002, Jul-26, Volume: 71, Issue:10

    Topics: Adrenergic beta-Antagonists; Animals; Ciliary Arteries; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione Transferase; Guanylate Cyclase; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Potassium; Propanolamines; Vasoconstrictor Agents; Vasodilation

2002
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Caspase 3; Caspases; Hypertension; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Proliferating Cell Nuclear Antigen; Propanolamines; Rats; Rats, Inbred SHR; Rats, Wistar

2002
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
    Nephron. Physiology, 2003, Volume: 93, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Propanolamines; Propranolol; Proteinuria; Rats; Rats, Inbred F344; Renin

2003